And Then There Were Five: CMS Approves Wolters Kluwer Lexi-Drugs® as the Fifth Recognized Authoritative Compendium

Patients, providers, and manufacturers seeking Medicare coverage of cancer drugs now have a new source to consult.

Read more: And Then There Were Five: CMS Approves Wolters Kluwer Lexi-Drugs® as the Fifth Recognized Authoritative Compendium
 


Download PDF Share Back To Listing
Loading data